Clinical Trial Update: Investigating the Utilisation and Effectiveness of Originator and Biosimilar Anti-TNF Agents

View source ↗

Summary

This clinical trial update examines how originator and biosimilar anti-TNF medications are used and how effective they are for rheumatoid arthritis, psoriatic a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Psoriatic Arthritis
• Rheumatoid Arthritis

Drugs mentioned

• Anti-TNF agents (originator and biosimilars)

Snippet

Sponsor: Opal Rheumatology Ltd. | Conditions: Rheumatoid Arthritis, Psoriatic Arthritis | Status: UNKNOWN